[The Conversation Africa] Pharmaceutical company Moderna announced on 7 March 2022 that it would develop a site in Kenya to manufacture COVID-19 vaccines. The company holds much of the key intellectual property relating to the messenger RNA (mRNA) vaccines. Due to their higher efficacy, mRNA vaccines are the preferred option in developed countries. They account for 92% of all vaccinations to date in the US and European Union.
- 518 views
Africa: How Drug Companies Are Sidestepping the WHO’s Technology Transfer Hub in Africa
- March 14, 2022
- 1 minute read